Anthony D'Amico

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Anatomy

Prostate

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Hu Jim C; Gu Xiangmei; Lipsitz Stuart R; Barry Michael J; D'Amico Anthony V; Weinberg Aaron C; Keating Nancy L
Comparative effectiveness of minimally invasive vs open radical prostatectomy.
Nguyen Paul L; Chen Ronald C; Clark Jack A; Cormack Robert A; Loffredo Marian; McMahon Elizabeth; Nguyen Angela U; Suh W Warren; Tempany Clare M; D'Amico Anthony V
Patient-reported quality of life after salvage brachytherapy for radio-recurrent prostate cancer: A prospective Phase II study.
D'Amico Anthony V; Chen Ming-Hui; Renshaw Andrew A; Loffredo Marian; Kantoff Philip W
Interval to testosterone recovery after hormonal therapy for prostate cancer and risk of death.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Anthony D'Amico (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Hu Jim C; Gu Xiangmei; Lipsitz Stuart R; Barry Michael J; D'Amico Anthony V; Weinberg Aaron C; Keating Nancy L
Comparative effectiveness of minimally invasive vs open radical prostatectomy.
JAMA : the journal of the American Medical Association 2009;302(14):1557-64.
2009: Nguyen Paul L; Chen Ronald C; Clark Jack A; Cormack Robert A; Loffredo Marian; McMahon Elizabeth; Nguyen Angela U; Suh W Warren; Tempany Clare M; D'Amico Anthony V
Patient-reported quality of life after salvage brachytherapy for radio-recurrent prostate cancer: A prospective Phase II study.
Brachytherapy 2009;8(4):345-52.
2009: D'Amico Anthony V; Chen Ming-Hui; Renshaw Andrew A; Loffredo Marian; Kantoff Philip W
Interval to testosterone recovery after hormonal therapy for prostate cancer and risk of death.
International journal of radiation oncology, biology, physics 2009;75(1):10-5.
2009: Chen Ronald C; Sadetsky Natalia; Chen Ming-Hui; Carroll Peter R; D'Amico Anthony V
Maximum vs. mono androgen blockade and the risk of recurrence in men with localized prostate cancer undergoing brachytherapy.
International journal of radiation oncology, biology, physics 2009;75(1):36-9.
2009: Nanda Akash; Chen Ming-Hui; Braccioforte Michelle H; Moran Brian J; D'Amico Anthony V
Hormonal therapy use for prostate cancer and mortality in men with coronary artery disease-induced congestive heart failure or myocardial infarction.
JAMA : the journal of the American Medical Association 2009;302(8):866-73.
2009: D'Amico Anthony V; Moran Brian J; Braccioforte Michelle H; Dosoretz Daniel; Salenius Sharon; Katin Michael; Ross Rudi; Chen Ming-Hui
Risk of death from prostate cancer after brachytherapy alone or with radiation, androgen suppression therapy, or both in men with high-risk disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(24):3923-8.
2009: Nanda Akash; Chen Ming-Hui; Renshaw Andrew A; D'Amico Anthony V
Gleason Pattern 5 prostate cancer: further stratification of patients with high-risk disease and implications for future randomized trials.
International journal of radiation oncology, biology, physics 2009;74(5):1419-23.
2009: Nguyen Paul L; Chen Ming-Hui; Hoffman Karen E; Katz Matthew S; D'Amico Anthony V
Predicting the risk of pelvic node involvement among men with prostate cancer in the contemporary era.
International journal of radiation oncology, biology, physics 2009;74(1):104-9.
2009: Nguyen Paul L; Chen Ming-Hui; Catalona William J; Moul Judd W; Sun Leon; D'Amico Anthony V
Predicting prostate cancer mortality among men with intermediate to high-risk disease and multiple unfavorable risk factors.
International journal of radiation oncology, biology, physics 2009;73(3):659-64.
2008: Nguyen Paul L; Chen Ming-Hui; Catalona William J; Alexander Brian M; Roehl Kimberly A; Loeb Stacy; D'Amico Anthony V
Biochemical recurrence after radical prostatectomy for prevalent versus incident cases of prostate cancer : implications for management.
Cancer 2008;113(11):3146-52.
2008: Nanda Akash; D'Amico Anthony V
Combined radiation and hormonal therapy or dose escalation for men with unfavourable-risk prostate cancer: an evidence-based approach using a synthesis of randomized clinical trials.
BJU international 2008;102(10):1366-8.
2008: Sommers Benjamin D; Beard Clair J; D'Amico Anthony V; Kaplan Irving; Richie Jerome P; Zeckhauser Richard J
Predictors of patient preferences and treatment choices for localized prostate cancer.
Cancer 2008;113(8):2058-67.
2008: Hoffman Karen E; Chen Ming-Hui; Punglia Rinaa S; Beard Clair J; D'Amico Anthony V
Influence of year of diagnosis, patient age, and sociodemographic status on recommending adjuvant radiation treatment for stage I testicular seminoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(24):3937-42.
2008: D'Amico Anthony V; Chen Ming-Hui; Renshaw Andrew A; Loffredo Brittany; Kantoff Philip W
Risk of prostate cancer recurrence in men treated with radiation alone or in conjunction with combined or less than combined androgen suppression therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(18):2979-83.
2008: Arlen Philip M; Bianco Fernando; Dahut William L; D'Amico Anthony; Figg William D; Freedland Stephen J; Gulley James L; Kantoff Philip W; Kattan Michael W; Lee Andrew; Regan Meredith M; Sartor Oliver;
Prostate Specific Antigen Working Group guidelines on prostate specific antigen doubling time.
The Journal of urology 2008;179(6):2181-5; discussion 2185-6.
2008: Macdonald O Kenneth; D'Amico Anthony V; Sadetsky Natalia; Shrieve Dennis C; Carroll Peter R
Predicting PSA failure following salvage radiotherapy for a rising PSA post-prostatectomy: from the CaPSURE database.
Urologic oncology 2008;26(3):271-5.
2008: Vira Manish A; Guzzo Thomas; Heitjan Daniel F; Tomaszewski John E; D'Amico Anthony; Wein Alan J; Malkowicz S Bruce
Is the biopsy Gleason score important in predicting outcomes for patients after radical prostatectomy once the pathological Gleason score is known?
BJU international 2008;101(10):1232-6.
2008: D'Amico Anthony V; Halabi Susan; Vollmer Robin; Loffredo Marian; McMahon Elizabeth; Sanford Ben; Archer Laura; Vogelzang Nicholas J; Small Eric J; Kantoff Philip W;
p53 protein expression status and recurrence in men treated with radiation and androgen suppression therapy for higher-risk prostate cancer: a prospective phase II Cancer and Leukemia Group B Study (CALGB 9682).
Urology 2008;71(5):933-7.
2008: D'Amico Anthony V; Halabi Susan; Tempany Clare; Titelbaum David; Philips George K; Loffredo Marian; McMahon Elizabeth; Sanford Ben; Vogelzang Nicholas J; Small Eric J;
Tumor volume changes on 1.5 tesla endorectal MRI during neoadjuvant androgen suppression therapy for higher-risk prostate cancer and recurrence in men treated using radiation therapy results of the phase II CALGB 9682 study.
International journal of radiation oncology, biology, physics 2008;71(1):9-15.
2008: Nguyen Paul L; D'Amico Anthony V
Targeting pelvic lymph nodes in men with intermediate- and high-risk prostate cancer despite two negative randomized trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(12):2055-6; author reply 2056-7.
2008: Albert Michele; Song Jun S; Schultz Delray; Cormack Robert A; Tempany Clare M; Haker Steve; Devlin Phillip M; Beard Clair; Hurwitz Mark D; Suh Wonsuk W; Jolesz Ferenc; D'Amico Anthony V
Defining the rectal dose constraint for permanent radioactive seed implantation of the prostate.
Urologic oncology 2008;26(2):147-52.
2008: Sengupta Shomik; Amling Christopher; D'Amico Anthony V; Blute Michael L
Prostate specific antigen kinetics in the management of prostate cancer.
The Journal of urology 2008;179(3):821-6.
2008: D'Amico Anthony V
Prostate-specific antigen (PSA) and PSA velocity: competitors or collaborators in the prediction of curable and clinically significant prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(6):823-4.
2008: Chung Christine S; Chen Ming-Hui; Cullen Jennifer; McLeod David; Carroll Peter; D'Amico Anthony V
Time to prostate-specific antigen nadir after androgen suppression therapy for postoperative or postradiation PSA failure and risk of prostate cancer-specific mortality.
Urology 2008;71(1):136-40.
2008: D'Amico Anthony V; Chen Ming-Hui; Renshaw Andrew A; Loffredo Marian; Kantoff Philip W
Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial.
JAMA : the journal of the American Medical Association 2008;299(3):289-95.
2007: D'Amico Anthony V; Kantoff Philip W; Chen Ming-Hui
Aspirin and hormone therapy for prostate cancer.
The New England journal of medicine 2007;357(26):2737-8.
2007: Sommers Benjamin D; Beard Clair J; D'Amico Anthony V; Dahl Douglas; Kaplan Irving; Richie Jerome P; Zeckhauser Richard J
Decision analysis using individual patient preferences to determine optimal treatment for localized prostate cancer.
Cancer 2007;110(10):2210-7.
2007: Punglia Rinaa S; Cullen Jennifer; McLeod David G; Chen Yongmei; D'Amico Anthony V
Prostate-specific antigen velocity and the detection of gleason score 7 to 10 prostate cancer.
Cancer 2007;110(9):1973-8.
2007: Tsai Henry K; D'Amico Anthony V; Sadetsky Natalia; Chen Ming-Hui; Carroll Peter R
Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality.
Journal of the National Cancer Institute 2007;99(20):1516-24.
2007: Patel Abhijit A; Chen Ming-Hui; Renshaw Andrew A; D'Amico Anthony V
PSA failure following definitive treatment of prostate cancer having biopsy Gleason score 7 with tertiary grade 5.
JAMA : the journal of the American Medical Association 2007;298(13):1533-8.
2007: D'Amico Anthony V; Renshaw Andrew A; Loffredo Brittany; Chen Ming-Hui
Duration of testosterone suppression and the risk of death from prostate cancer in men treated using radiation and 6 months of hormone therapy.
Cancer 2007;110(8):1723-8.
2007: Nguyen Paul L; Chen Ming-Hui; D'Amico Anthony V; Tempany Clare M; Steele Graeme S; Albert Michele; Cormack Robert A; Carr-Locke David L; Bleday Ronald; Suh W Warren
Magnetic resonance image-guided salvage brachytherapy after radiation in select men who initially presented with favorable-risk prostate cancer: a prospective phase 2 study.
Cancer 2007;110(7):1485-92.
2007: Nguyen Paul L; D'Amico Anthony V; Lee Andrew K; Suh W Warren
Patient selection, cancer control, and complications after salvage local therapy for postradiation prostate-specific antigen failure: a systematic review of the literature.
Cancer 2007;110(7):1417-28.
2007: Kantoff Philip W; Beer Tomasz M; D'Amico Anthony V; Dipaola Robert S; Eisenberger Mario A; Hussain Maha H A; Kelly William Kevin; Mathew Paul; Morris Michael J; Ryan Charles J; Sandler Howard M; Thompson Ian M; Carroll Peter R
Innovations and challenges in prostate cancer: summary statement for the 6th Cambridge Conference.
The Journal of urology 2007;178(3 Pt 2):S5-8; quiz S4.
2007: Alexander Brian M; Chen Ming-Hui; Carroll Peter; D'Amico Anthony V
Prostate-specific antigen level at initiation of hormonal therapy after prostate-specific antigen failure following prostatectomy or radiotherapy and therapeutic response.
Urology 2007;70(2):320-3.
2007: Nguyen Paul L; Chen Ming-Hui; Renshaw Andrew A; Sussman Brenda; D'Amico Anthony V
Effect of definition of preradiotherapy prostate-specific antigen velocity on its association with prostate cancer-specific mortality and all-cause mortality.
Urology 2007;70(2):288-93.
2007: Mohler James; Babaian Richard J; Bahnson Robert R; Boston Barry; D'Amico Anthony; Eastham James A; Hauke Ralph J; Huben Robert P; Kantoff Philip; Kawachi Mark; Kuettel Michael; Lange Paul H; Logothetis Chris; MacVicar Gary; Pollack Alan; Pow-Sang Julio M; Roach Mack; Sandler Howard; Shrieve Dennis; Srinivas Sandhya; Twardowski Przemyslaw; Urban Donald A; Walsh Patrick C;
Prostate cancer. Clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2007;5(7):650-83.
2007: Lee Andrew K; D'Amico Anthony V
Using prostate-specific antigen doubling time in clinical practice.
BJU international 2007;100(2):243-4.
2007: Macdonald O Kenneth; D'Amico Anthony V; Sadetsky Natalia; Shrieve Dennis C; Carroll Peter R
Adjuvant radiotherapy in prostate cancer: predictors of prostate-specific antigen recurrence from the CaPSURE database.
Urology 2007;70(1):106-10.
2007: D'Amico Anthony V; Chen Ming-Hui; Catalona William J; Sun Leon; Roehl Kimberly A; Moul Judd W
Prostate cancer-specific mortality after radical prostatectomy or external beam radiation therapy in men with 1 or more high-risk factors.
Cancer 2007;110(1):56-61.
2007: D'Amico Anthony V; Denham James W; Crook Juanita; Chen Ming-Hui; Goldhaber Samuel Z; Lamb David S; Joseph David; Tai Keen-Hun; Malone Shawn; Ludgate Charles; Steigler Allison; Kantoff Philip W
Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctions.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(17):2420-5.
2007: D'Amico Anthony V; Denham James W; Bolla Michel; Collette Laurence; Lamb David S; Tai Keen-Hun; Steigler Allison; Chen Ming-Hui
Short- vs long-term androgen suppression plus external beam radiation therapy and survival in men of advanced age with node-negative high-risk adenocarcinoma of the prostate.
Cancer 2007;109(10):2004-10.
2007: Balboni Tracy A; Chen Ming-Hui; Harris Jay R; Recht Abram; Stevenson Mary Ann; D'Amico Anthony V
Academic career selection and retention in radiation oncology: the Joint Center for Radiation Therapy experience.
International journal of radiation oncology, biology, physics 2007;68(1):183-6.
2007: Efstathiou Jason A; Chen Ming-Hui; Renshaw Andrew A; Loffredo Marian J; D'Amico Anthony V
Influence of body mass index on prostate-specific antigen failure after androgen suppression and radiation therapy for localized prostate cancer.
Cancer 2007;109(8):1493-8.
2007: D'Amico Anthony V; McLeod David G; Carroll Peter R; Cullen Jennifer; Chen Ming-Hui
Time to an undetectable prostate-specific antigen (PSA) after androgen suppression therapy for postoperative or postradiation PSA recurrence and prostate cancer-specific mortality.
Cancer 2007;109(7):1290-5.
2007: Krejcarek Stephanie C; Chen Ming-Hui; Renshaw Andrew A; Loffredo Marian; Sussman Brenda; D'Amico Anthony V
Prediagnostic prostate-specific antigen velocity and probability of detecting high-grade prostate cancer.
Urology 2007;69(3):515-9.
2007: D'Amico Anthony
Global update on defining and treating high-risk localized prostate cancer with leuprorelin: a USA perspective--identifying men at diagnosis who are at high risk of prostate cancer death after surgery or radiation therapy.
BJU international 2007;99 Suppl 1():13-6; discussion 17-8.
2007: D'Amico Anthony V; Roehrborn Claus G
Effect of 1 mg/day finasteride on concentrations of serum prostate-specific antigen in men with androgenic alopecia: a randomised controlled trial.
The lancet oncology 2007;8(1):21-5.
2007: D'Amico Anthony V
Toward the optimal use of androgen suppression therapy in the radiotherapeutic management of prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(1):8-9.
2006: D'Amico Anthony V; Hui-Chen Ming; Renshaw Andrew A; Sussman Brenda; Roehl Kimberly A; Catalona William J
Identifying men diagnosed with clinically localized prostate cancer who are at high risk for death from prostate cancer.
The Journal of urology 2006;176(6 Pt 2):S11-5.
2006: Tsai Henry K; Chen Ming-Hui; McLeod David G; Carroll Peter R; Richie Jerome P; D'Amico Anthony V
Cancer-specific mortality after radiation therapy with short-course hormonal therapy or radical prostatectomy in men with localized, intermediate-risk to high-risk prostate cancer.
Cancer 2006;107(11):2597-603.
2006: Chen Aileen B; D'Amico Anthony V; Neville Bridget A; Earle Craig C
Patient and treatment factors associated with complications after prostate brachytherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(33):5298-304.
2006: D'Amico Anthony V; Barry Michael J
Prostate cancer prevention and finasteride.
The Journal of urology 2006;176(5):2010-2; discussion 2012-3.
2006: Court Laurence E; D'Amico Anthony V; Kadam Dnyanesh; Cormack Robert
Motion and shape change when using an endorectal balloon during prostate radiation therapy.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2006;81(2):184-9.
2006: Petit Joshua H; Chen Ming-Hui; Loffredo Marian; Sussman Brenda; Renshaw Andrew A; D'Amico Anthony V
Prostate-specific antigen recurrence and mortality after conventional dose radiation therapy in select men with low-risk prostate cancer.
Cancer 2006;107(9):2180-5.
2006: Beard Clair; Schultz Delray; Loffredo Marian; Cote Kerri; Renshaw Andrew A; Hurwitz Mark D; D'Amico Anthony V
Perineural invasion associated with increased cancer-specific mortality after external beam radiation therapy for men with low- and intermediate-risk prostate cancer.
International journal of radiation oncology, biology, physics 2006;66(2):403-7.
2006: D'Amico Anthony V; Loffredo Marian; Renshaw Andrew A; Loffredo Brittany; Chen Ming-Hui
Six-month androgen suppression plus radiation therapy compared with radiation therapy alone for men with prostate cancer and a rapidly increasing pretreatment prostate-specific antigen level.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(25):4190-5.
2006: Hurwitz Mark D; Schultz Delray; Richie Jerome P; Wein Alan J; Whittington Richard; Malkowicz S Bruce; D'Amico Anthony V
Radical prostatectomy for high-grade prostate cancer.
Urology 2006;68(2):367-70.
2006: Efstathiou Jason A; Chen Ming-Hui; Catalona William J; McLeod David G; Carroll Peter R; Moul Judd W; Roehl Kimberly A; D'Amico Anthony V
Prostate-specific antigen-based serial screening may decrease prostate cancer-specific mortality.
Urology 2006;68(2):342-7.
2006: Rodrigues Neesha A; Chen Ming-Hui; Catalona William J; Roehl Kimberly A; Richie Jerome P; D'Amico Anthony V
Predictors of mortality after androgen-deprivation therapy in patients with rapidly rising prostate-specific antigen levels after local therapy for prostate cancer.
Cancer 2006;107(3):514-20.
2006: D'Amico Anthony V; Kantoff Phillip; Loffredo Marian; Renshaw Andrew A; Loffredo Brittany; Chen Ming-Hui
Predictors of mortality after prostate-specific antigen failure.
International journal of radiation oncology, biology, physics 2006;65(3):656-60.
2006: D'Amico Anthony V; Manola Judith; McMahon Elizabeth; Loffredo Marian; Lopes Lynn; Ching Jane; Albert Michele; Hurwitz Mark; Suh Wonsuk Warren; Vivenzio Todd A; Beard Clair
A prospective evaluation of rectal bleeding after dose-escalated three-dimensional conformal radiation therapy using an intrarectal balloon for prostate gland localization and immobilization.
Urology 2006;67(4):780-4.
2006: Punglia Rinaa S; D'Amico Anthony V; Catalona William J; Roehl Kimberly A; Kuntz Karen M
Impact of age, benign prostatic hyperplasia, and cancer on prostate-specific antigen level.
Cancer 2006;106(7):1507-13.
2006: Galper Shira L; Chen Ming-Hui; Catalona William J; Roehl Kimberly A; Richie Jerome P; D'Amico Anthony V
Evidence to support a continued stage migration and decrease in prostate cancer specific mortality.
The Journal of urology 2006;175(3 Pt 1):907-12.
2006: Guzzo Thomas J; Vira Manish; Wang Yanlin; Tomaszewski John; D'amico Anthony; Wein Alan J; Malkowicz S Bruce
Preoperative parameters, including percent positive biopsy, in predicting seminal vesicle involvement in patients with prostate cancer.
The Journal of urology 2006;175(2):518-21; discussion 521-2.
2006: Rozhansky Flora; Chen Ming-Hui; Cox Michael C; Dahut William; Figg William D; D'Amico Anthony V
Prostate-specific antigen velocity and survival for patients with hormone-refractory metastatic prostate carcinoma.
Cancer 2006;106(1):63-7.
2005: Barnes Agnieszka Szot; Haker Steven J; Mulkern Robert V; So Minna; D'Amico Anthony V; Tempany Clare M
Magnetic resonance spectroscopy-guided transperineal prostate biopsy and brachytherapy for recurrent prostate cancer.
Urology 2005;66(6):1319.
2005: Punglia Rinaa S; Kuntz Karen M; Catalona William J; D'Amico Anthony
Operating characteristics of prostate-specific antigen and verification bias.
JAMA : the journal of the American Medical Association 2005;294(21):2698; author reply 2698-9.
2005: Kadoch Cigall; D'Amico Anthony V; Matthews Richard H
When prostate brachytherapy fails: a case report and discussion.
The oncologist 2005;10(10):799-805.
2005: Dvorak Tomas; Chen Ming-Hui; Renshaw Andrew A; Loffredo Marian; Richie Jerome P; D'Amico Anthony V
Maximal tumor diameter and the risk of PSA failure in men with specimen-confined prostate cancer.
Urology 2005;66(5):1024-8.
2005: Beard Clair; Chen Ming-Hui; Cote Kerri; Loffredo Marian; Renshaw Andrew; Hurwitz Mark; D'Amico Anthony V
Pretreatment predictors of posttreatment PSA doubling times for patients undergoing three-dimensional conformal radiotherapy for clinically localized prostate cancer.
Urology 2005;66(5):1020-3.
2005: Vira Manish A; Tomaszewski John E; Hwang Wei-Ting; D'Amico Anthony V; Whittington Richard; Vanarsdalen Keith; Wein Alan J; Malkowicz S Bruce
Impact of the percentage of positive biopsy cores on the further stratification of primary grade 3 and grade 4 Gleason score 7 tumors in radical prostatectomy patients.
Urology 2005;66(5):1015-9.
2005: Lee Andrew K; D'Amico Anthony V
Utility of prostate-specific antigen kinetics in addition to clinical factors in the selection of patients for salvage local therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(32):8192-7.
2005: Zhou Ping; Chen Ming-Hui; McLeod David; Carroll Peter R; Moul Judd W; D'Amico Anthony V
Predictors of prostate cancer-specific mortality after radical prostatectomy or radiation therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(28):6992-8.
2005: Stewart Alexandra J; Scher Howard I; Chen Ming-Hui; McLeod David G; Carroll Peter R; Moul Judd W; D'Amico Anthony V
Prostate-specific antigen nadir and cancer-specific mortality following hormonal therapy for prostate-specific antigen failure.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(27):6556-60.
2005: McAleer Sarah J; Schultz Delray; Whittington Richard; Malkowicz S Bruce; Renshaw Andrew; Wein Alan; Richie Jerome P; D'Amico Anthony V
PSA outcome following radical prostatectomy for patients with localized prostate cancer stratified by prostatectomy findings and the preoperative PSA level.
Urologic oncology 2005;23(5):311-7.
2005: D'Amico Anthony V; Chen Ming-Hui; Cox Michael C; Dahut William; Figg William D
Prostate-specific antigen response duration and risk of death for patients with hormone-refractory metastatic prostate cancer.
Urology 2005;66(3):571-6.
2005: Guzzo Thomas J; Vira Manish; Hwang Wei-Ting; D'amico Anthony; Tomaszewski John; Whittington Richard; Wein Alan J; Vanarsdalen Keith; Malkowicz S Bruce
Impact of multiple biopsy cores on predicting final tumor volume in prostate cancer detected by a single microscopic focus of cancer on biopsy.
Urology 2005;66(2):361-5.
2005: D'Amico Anthony V; Chen Ming-Hui; Roehl Kimberly A; Catalona William J
Identifying patients at risk for significant versus clinically insignificant postoperative prostate-specific antigen failure.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(22):4975-9.
2005: D'Amico Anthony V; Renshaw Andrew A; Sussman Brenda; Chen Ming-Hui
Pretreatment PSA velocity and risk of death from prostate cancer following external beam radiation therapy.
JAMA : the journal of the American Medical Association 2005;294(4):440-7.
2005: Tsai Henry K; Manola Judith; Abner Anthony; Talcott James A; D'Amico Anthony V; Beard Clair
Patient-reported acute gastrointestinal toxicity in men receiving 3-dimensional conformal radiation therapy for prostate cancer with or without neoadjuvant androgen suppression therapy.
Urologic oncology 2005;23(4):230-7.
2005: Woel Rosemonde; Beard Clair; Chen Ming-Hui; Hurwitz Mark; Loffredo Marian; McMahon Elizabeth; Ching Jane; Lopes Lynn; D'Amico Anthony V
Acute gastrointestinal, genitourinary, and dermatological toxicity during dose-escalated 3D-conformal radiation therapy (3DCRT) using an intrarectal balloon for prostate gland localization and immobilization.
International journal of radiation oncology, biology, physics 2005;62(2):392-6.
2005: D'Amico Anthony V; Moul Judd; Carroll Peter R; Sun Leon; Lubeck Deborah; Chen Ming-Hui
Surrogate end point for prostate cancer specific mortality in patients with nonmetastatic hormone refractory prostate cancer.
The Journal of urology 2005;173(5):1572-6.
2005: Nguyen Paul L; Whittington Richard; Koo Sophia; Schultz Delray; Cote Kerri B; Loffredo Marian; McMahon Elizabeth; Renshaw Andrew A; Tomaszewski John E; D'Amico Anthony V
The impact of a delay in initiating radiation therapy on prostate-specific antigen outcome for patients with clinically localized prostate carcinoma.
Cancer 2005;103(10):2053-9.
2005: Landis Daniel M; Schultz Delray; Cormack Robert; Tempany Clare; Beard Clair; Hurwitz Mark; O'Leary Michael; Albert Michele; Valentine Kristin; D'Amico Anthony V
Acute urinary retention after magnetic resonance image-guided prostate brachytherapy with and without neoadjuvant external beam radiotherapy.
Urology 2005;65(4):750-4.
2005: Lin Darlene D; Schultz Delray; Renshaw Andrew A; Rubin Mark A; Richie Jerome P; D'Amico Anthony V
Predictors of short postoperative prostate-specific antigen doubling time for patients diagnosed during PSA era.
Urology 2005;65(3):528-32.
2005: D'Amico Anthony V
Screening for prostate carcinoma: prostate-specific antigen--friend or foe?
Cancer 2005;103(5):881-3.
2005: Song Jun S; Albert Michele; D'Amico Anthony V; Cormack Robert A
A comparative study of rectal dose histograms in prostate brachytherapy: some analytic and numerical results.
Medical physics 2005;32(2):437-47.
2004: D'Amico Anthony V; Moul Judd; Carroll Peter R; Sun Leon; Lubeck Deborah; Chen Ming-Hui
Prostate specific antigen doubling time as a surrogate end point for prostate cancer specific mortality following radical prostatectomy or radiation therapy.
The Journal of urology 2004;172(5 Pt 2):S42-6; discussion S46-7.
2004: D'Amico Anthony V; Renshaw Andrew A; Cote Kerri; Hurwitz Mark; Beard Clair; Loffredo Marian; Chen Ming-Hui
Impact of the percentage of positive prostate cores on prostate cancer-specific mortality for patients with low or favorable intermediate-risk disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(18):3726-32.
2004: D'Amico Anthony V; Manola Judith; Loffredo Marian; Renshaw Andrew A; DellaCroce Alyssa; Kantoff Philip W
6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2004;292(7):821-7.
2004: Nguyen Paul L; Schultz Delray; Renshaw Andrew A; Vollmer Robin T; Welch William R; Cote Kerri; D'Amico Anthony V
The impact of pathology review on treatment recommendations for patients with adenocarcinoma of the prostate.
Urologic oncology 2004;22(4):295-9.
2004: D'Amico Anthony V; Chen Ming-Hui; Roehl Kimberly A; Catalona William J
Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy.
The New England journal of medicine 2004;351(2):125-35.
2004: Seo Pearl H; D'Amico Anthony V; Clark Jack A; Kaplan Irving; Manola Judith B; Mitchell Sonya P; Talcott James A
Assessing a prostate cancer brachytherapy technique using early patient-reported symptoms: a potential early indicator for technology assessment?
Clinical prostate cancer 2004;3(1):38-42.
2004: Kelloff Gary J; Coffey Donald S; Chabner Bruce A; Dicker Adam P; Guyton Kathryn Z; Nisen Perry D; Soule Howard R; D'Amico Anthony V
Prostate-specific antigen doubling time as a surrogate marker for evaluation of oncologic drugs to treat prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(11):3927-33.
2004: Kelloff Gary J; Bast Robert C; Coffey Donald S; D'Amico Anthony V; Kerbel Robert S; Park John W; Ruddon Raymond W; Rustin Gordon J S; Schilsky Richard L; Sigman Caroline C; Woude George F Vande
Biomarkers, surrogate end points, and the acceleration of drug development for cancer prevention and treatment: an update prologue.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(11):3881-4.
2004: Nguyen Paul L; Whittington Richard; Koo Sophia; Schultz Delray; Cote Kerri B; Loffredo Marian; Tempany Clare M; Titelbaum David S; Schnall Mitchell D; Renshaw Andrew A; Tomaszewski John E; D'Amico Anthony V
Quantifying the impact of seminal vesicle invasion identified using endorectal magnetic resonance imaging on PSA outcome after radiation therapy for patients with clinically localized prostate cancer.
International journal of radiation oncology, biology, physics 2004;59(2):400-5.
2004: Sanghani Mona V; Ching Jane; Schultz Delray; Cormack Robert; Loffredo Marian; McMahon Elizabeth; Beard Clair; D'Amico Anthony V
Impact on rectal dose from the use of a prostate immobilization and rectal localization device for patients receiving dose escalated 3D conformal radiation therapy.
Urologic oncology 2004;22(3):165-8.
2004: D'Amico Anthony V; Moul Judd W; Carroll Peter R; Cote Kerri; Sun Leon; Lubeck Deborah; Renshaw Andrew A; Loffredo Marian; Chen Ming-Hui
Intermediate end point for prostate cancer-specific mortality following salvage hormonal therapy for prostate-specific antigen failure.
Journal of the National Cancer Institute 2004;96(7):509-15.
2004: Bloom Keith D; Richie Jerome P; Schultz Delray; Renshaw Andrew; Saegaert Tara; D'amico Anthony V
Invasion of seminal vesicles by adenocarcinoma of the prostate: PSA outcome determined by preoperative and postoperative factors.
Urology 2004;63(2):333-6.
2004: Scher Howard I; Eisenberger Mario; D'Amico Anthony V; Halabi Susan; Small Eric J; Morris Michael; Kattan Michael W; Roach Mack; Kantoff Philip; Pienta Kenneth J; Carducci Michael A; Agus David; Slovin Susan F; Heller Glenn; Kelly William Kevin; Lange Paul H; Petrylak Daniel; Berg William; Higano Celestra; Wilding George; Moul Judd W; Partin Alan N; Logothetis Christopher; Soule Howard R
Eligibility and outcomes reporting guidelines for clinical trials for patients in the state of a rising prostate-specific antigen: recommendations from the Prostate-Specific Antigen Working Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(3):537-56.
2004: Beard C J; Chen M H; Cote K; Loffredo M; Renshaw A A; Hurwitz M; D'Amico A V
Perineural invasion is associated with increased relapse after external beam radiotherapy for men with low-risk prostate cancer and may be a marker for occult, high-grade cancer.
International journal of radiation oncology, biology, physics 2004;58(1):19-24.
2004: Dickhaus Christoph F; Burghart Catherina; Tempany Clare; D'Amico Anthony; Haker Steven; Kikinis Ron; Woern Heinz
Workflow modeling and analysis of computer guided prostate brachytherapy under MR imaging control.
Studies in health technology and informatics 2004;98():72-4.
2003: Cooperberg M R; Small E J; D'Amico A; Carroll P R
The evolving role of androgen deprivation therapy in the management of prostate cancer.
Minerva urologica e nefrologica = The Italian journal of urology and nephrology 2003;55(4):219-38.
2003: D'amico Anthony V; Tempany Clare M; Schultz Delray; Cormack Robert A; Hurwitz Mark; Beard Clair; Albert Michele; Kooy Hanne; Jolesz Ferenc; Richie Jerome P
Comparing PSA outcome after radical prostatectomy or magnetic resonance imaging-guided partial prostatic irradiation in select patients with clinically localized adenocarcinoma of the prostate.
Urology 2003;62(6):1063-7.
2003: D'Amico Anthony V; Cote Kerri; Loffredo Marian; Renshaw Andrew A; Schultz Delray
Determinants of prostate cancer specific survival following radiation therapy during the prostate specific antigen era.
The Journal of urology 2003;170(6 Pt 2):S42-6; discussion S46-7.
2003: Talcott James A; Manola Judithy; Clark Jack A; Kaplan Irving; Beard Clair J; Mitchell Sonya P; Chen Ronald C; O'Leary Michael P; Kantoff Philip W; D'Amico Anthony V
Time course and predictors of symptoms after primary prostate cancer therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(21):3979-86.
2003: D'Amico Anthony V; Moul Judd W; Carroll Peter R; Sun Leon; Lubeck Deborah; Chen Ming-Hui
Surrogate end point for prostate cancer-specific mortality after radical prostatectomy or radiation therapy.
Journal of the National Cancer Institute 2003;95(18):1376-83.
2003: Sanghani Mona V; Schultz Delray; Tempany Clare M; Titelbaum David; Renshaw Andrew A; Loffredo Marian; Cote Kerri; McMahon Beth; D'Amico Anthony V
Quantifying the change in endorectal magnetic resonance imaging-defined tumor volume during neoadjuvant androgen suppression therapy in patients with prostate cancer.
Urology 2003;62(3):487-91.
2003: Albert Michele; Tempany Clare M; Schultz Delray; Chen Ming-Hui; Cormack Robert A; Kumar Sanjaya; Hurwitz Mark D; Beard Clair; Tuncali Kemal; O'Leary Michael; Topulos George P; Valentine Kristin; Lopes Lynn; Kanan Angela; Kacher Daniel; Rosato James; Kooy Hanne; Jolesz Ferenc; Carr-Locke David L; Richie Jerome P; D'Amico Anthony V
Late genitourinary and gastrointestinal toxicity after magnetic resonance image-guided prostate brachytherapy with or without neoadjuvant external beam radiation therapy.
Cancer 2003;98(5):949-54.
2003: Renshaw Andrew A; Schultz Delray; Cote Kerri; Loffredo Marian; Ziemba David E; D'Amico Anthony V
Accurate Gleason grading of prostatic adenocarcinoma in prostate needle biopsies by general pathologists.
Archives of pathology & laboratory medicine 2003;127(8):1007-8.
2003: Punglia Rinaa S; D'Amico Anthony V; Catalona William J; Roehl Kimberly A; Kuntz Karen M
Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen.
The New England journal of medicine 2003;349(4):335-42.
2003: D'Amico Anthony V; Moul Judd; Carroll Peter R; Sun Leon; Lubeck Deborah; Chen Ming-Hui
Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(11):2163-72.
2003: D'Amico Anthony V; Cote Kerri; Loffredo Marian; Renshaw Andrew A; Chen Ming-Hui
Pretreatment predictors of time to cancer specific death after prostate specific antigen failure.
The Journal of urology 2003;169(4):1320-4.
2003: Lee Andrew K; Doytchinova Tatiana; Chen Ming-Hui; Renshaw Andrew A; Weinstein Michael; Richie Jerome P; D'Amico Anthony V
Can the core length involved with prostate cancer identify clinically insignificant disease in low risk patients diagnosed on the basis of a single positive core?
Urologic oncology 2003;21(2):123-7.
2003: Cheng George C; Chen Ming Hui; Whittington Richard; Malkowicz S Bruce; Schnall Mitchell D; Tomaszewski John E; D'Amico Anthony V
Clinical utility of endorectal MRI in determining PSA outcome for patients with biopsy Gleason score 7, PSA <or=10, and clinically localized prostate cancer.
International journal of radiation oncology, biology, physics 2003;55(1):64-70.
2003: D'Amico Anthony V; Cote Kerri; Loffredo Marian; Renshaw Andrew A; Chen Ming-Hui
Advanced age at diagnosis is an independent predictor of time to death from prostate carcinoma for patients undergoing external beam radiation therapy for clinically localized prostate carcinoma.
Cancer 2003;97(1):56-62.
2003: D'Amico Anthony V
Therapeutic strategies for localized and locally advanced prostate cancer: combining androgen suppression with definitive local therapy.
Reviews in urology 2003;5 Suppl 6():S40-6.
2002: D'Amico Anthony V; Toupless George; Lopes Lynn; Valentine Kristin J; Cormack Robert A; Tempany Clare M; Kumar Sanjaya; Marks Peter J
Self-administration of untested medical therapy for treatment of prostate cancer can lead to clinically significant adverse events.
International journal of radiation oncology, biology, physics 2002;54(5):1311-3.
2002: D'Amico Anthony V; Cote Kerri; Loffredo Marian; Renshaw Andrew A; Schultz Delray
Determinants of prostate cancer-specific survival after radiation therapy for patients with clinically localized prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(23):4567-73.
2002: D'Amico Anthony V
How to compare results after surgery or radiation for localized prostate carcinoma.
Cancer 2002;95(10):2041-3.
2002: Das Prajnan; Chen Ming-H; Valentine Kristin; Lopes Lynn; Cormack Robert A; Renshaw Andrew A; Tempany Clare M; Kumar Sanjaya; D'Amico Anthony V
Using the magnitude of PSA bounce after MRI-guided prostate brachytherapy to distinguish recurrence, benign precipitating factors, and idiopathic bounce.
International journal of radiation oncology, biology, physics 2002;54(3):698-702.
2002: D'Amico Anthony V; Chen Ming-Hui; Oh-Ung Jean; Renshaw Andrew A; Cote Kerri; Loffredo Marian; Richie Jerome P
Changing prostate-specific antigen outcome after surgery or radiotherapy for localized prostate cancer during the prostate-specific antigen era.
International journal of radiation oncology, biology, physics 2002;54(2):436-41.
2002: Ung Jean O; Richie Jerome P; Chen Ming-Hui; Renshaw Andrew A; D'Amico Anthony V
Evolution of the presentation and pathologic and biochemical outcomes after radical prostatectomy for patients with clinically localized prostate cancer diagnosed during the PSA era.
Urology 2002;60(3):458-63.
2002: Yoon Jeong H; Chen Ming-Hui; Renshaw Andrew A; Richie Jerome P; D'Amico Anthony V
Predictive factor analysis as the basis for the clinical utility of percent positive prostate biopsies in patients with intermediate-risk prostate cancer.
Urology 2002;60(3):454-7.
2002: D'Amico Anthony V
Radiation and hormonal therapy for locally advanced and clinically localized prostate cancer.
Urology 2002;60(3 Suppl 1):32-7; discussion 37-8.
2002: Hirose Masanori; Bharatha Aditya; Hata Nobuhiko; Zou Kelly H; Warfield Simon K; Cormack Robert A; D'Amico Anthony; Kikinis Ron; Jolesz Ferenc A; Tempany Clare M C
Quantitative MR imaging assessment of prostate gland deformation before and during MR imaging-guided brachytherapy.
Academic radiology 2002;9(8):906-12.
2002: D'Amico Anthony V
Predicting prostate-specific antigen recurrence established: now, who will survive?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(15):3188-90.
2002: Hurwitz Mark D; Schnieder Lindsey; Manola Judith; Beard Clair J; Kaplan Irving D; D'Amico Anthony V
Lack of radiation dose response for patients with low-risk clinically localized prostate cancer: a retrospective analysis.
International journal of radiation oncology, biology, physics 2002;53(5):1106-10.
2002: D'Amico Anthony V; Whittington Richard; Malkowicz S Bruce; Cote Kerri; Loffredo Marian; Schultz Delray; Chen Ming-Hui; Tomaszewski John E; Renshaw Andrew A; Wein Alan; Richie Jerome P
Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era.
Cancer 2002;95(2):281-6.
2002: D'Amico Anthony V; Saegaert Tara; Chen Ming-Hui; Renshaw Andrew A; George Daniel; Oh William; Kantoff Philip W
Initial decline in hemoglobin during neoadjuvant hormonal therapy predicts for early prostate specific antigen failure following radiation and hormonal therapy for patients with intermediate and high-risk prostate cancer.
Cancer 2002;95(2):275-80.
2002: Lieberfarb Marshal E; Schultz Delray; Whittington Richard; Malkowicz Bruce; Tomaszewski John E; Weinstein Michael; Wein Alan; Richie Jerome P; D'Amico Anthony V
Using PSA, biopsy Gleason score, clinical stage, and the percentage of positive biopsies to identify optimal candidates for prostate-only radiation therapy.
International journal of radiation oncology, biology, physics 2002;53(4):898-903.
2002: D'Amico Anthony V; Keshaviah Aparna; Manola Judith; Cote Kerri; Loffredo Marian; Iskrzytzky Olga; Renshaw Andrew A
Clinical utility of the percentage of positive prostate biopsies in predicting prostate cancer-specific and overall survival after radiotherapy for patients with localized prostate cancer.
International journal of radiation oncology, biology, physics 2002;53(3):581-7.
2002: Cross Chaundre K; Shultz Delray; Malkowicz S Bruce; Huang William C; Whittington Richard; Tomaszewski John E; Renshaw Andrew A; Richie Jerome P; D'Amico Anthony V
Impact of race on prostate-specific antigen outcome after radical prostatectomy for clinically localized adenocarcinoma of the prostate.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(12):2863-8.
2002: Linson Patrick W; Lee Andrew K; Doytchinova Tatiana; Chen Ming-Hui; Weinstein Michael H; Richie Jerome P; D'Amico Anthony V
Percentage of core lengths involved with prostate cancer: does it add to the percentage of positive prostate biopsies in predicting postoperative prostate-specific antigen outcome for men with intermediate-risk prostate cancer?
Urology 2002;59(5):704-8.
2002: D'Amico Anthony V; Chen Ming-Hui; Malkowicz S Bruce; Whittington Richard; Renshaw Andrew A; Tomaszewski John E; Samofalov Yelina; Wein Alan; Richie Jerome P
Lower prostate specific antigen outcome than expected following radical prostatectomy in patients with high grade prostate and a prostatic specific antigen level of 4 ng/ml. Or less.
The Journal of urology 2002;167(5):2025-30; discussion 2030-1.
2002: Singh Dinesh; Febbo Phillip G; Ross Kenneth; Jackson Donald G; Manola Judith; Ladd Christine; Tamayo Pablo; Renshaw Andrew A; D'Amico Anthony V; Richie Jerome P; Lander Eric S; Loda Massimo; Kantoff Philip W; Golub Todd R; Sellers William R
Gene expression correlates of clinical prostate cancer behavior.
Cancer cell 2002;1(2):203-9.
2001: Bharatha A; Hirose M; Hata N; Warfield S K; Ferrant M; Zou K H; Suarez-Santana E; Ruiz-Alzola J; D'Amico A; Cormack R A; Kikinis R; Jolesz F A; Tempany C M
Evaluation of three-dimensional finite element-based deformable registration of pre- and intraoperative prostate imaging.
Medical physics 2001;28(12):2551-60.
2001: D'Amico A V; Manola J; Loffredo M; Lopes L; Nissen K; O'Farrell D A; Gordon L; Tempany C M; Cormack R A
A practical method to achieve prostate gland immobilization and target verification for daily treatment.
International journal of radiation oncology, biology, physics 2001;51(5):1431-6.
2001: D'Amico A V; Whittington R; Malkowicz S B; Weinstein M; Tomaszewski J E; Schultz D; Rhude M; Rocha S; Wein A; Richie J P
Predicting prostate specific antigen outcome preoperatively in the prostate specific antigen era.
The Journal of urology 2001;166(6):2185-8.
2001: D'Amico A V
Perineural invasion as a predictor of PSA outcome following local therapy for patients with clinically localized prostate cancer.
Cancer journal (Sudbury, Mass.) 2001;7(5):375-6.
2001: D'Amico A V; Whittington R; Malkowicz S B; Renshaw A A; Tomaszewski J E; Bentley C; Schultz D; Rocha S; Wein A; Richie J P
Estimating the impact on prostate cancer mortality of incorporating prostate-specific antigen testing into screening.
Urology 2001;58(3):406-10.
2001: Cheung R; Altschuler M D; D'Amico A V; Malkowicz S B; Wein A J; Whittington R
Using the receiver operating characteristic curve to select pretreatment and pathologic predictors for early and late postprostatectomy PSA failure.
Urology 2001;58(3):400-5.
2001: D'Amico A V
Combined-modality staging for localized adenocarcinoma of the prostate.
Oncology (Williston Park, N.Y.) 2001;15(8):1049-59; discussion 1060-2, 1064-5, 1069-70,1073-5.
2001: D'Amico A
Radiation and hormonal therapy for locally advanced and clinically localized prostate cancer.
Urology 2001;58(2 Suppl 1):78-82.
2001: Hata N; Jinzaki M; Kacher D; Cormak R; Gering D; Nabavi A; Silverman S G; D'Amico A V; Kikinis R; Jolesz F A; Tempany C M
MR imaging-guided prostate biopsy with surgical navigation software: device validation and feasibility.
Radiology 2001;220(1):263-8.
2001: D'Amico A V; Cormack R A; Tempany C M
MRI-guided diagnosis and treatment of prostate cancer.
The New England journal of medicine 2001;344(10):776-7.
2001: D'Amico A V; Schultz D; Silver B; Henry L; Hurwitz M; Kaplan I; Beard C J; Renshaw A A
The clinical utility of the percent of positive prostate biopsies in predicting biochemical outcome following external-beam radiation therapy for patients with clinically localized prostate cancer.
International journal of radiation oncology, biology, physics 2001;49(3):679-84.
2001: Lee A K; Schultz D; Renshaw A A; Richie J P; D'Amico A V
Optimizing patient selection for prostate monotherapy.
International journal of radiation oncology, biology, physics 2001;49(3):673-7.
2001: Cheung R; Altschuler M D; D'Amico A V; Malkowicz S B; Wein A J; Whittington R
ROC optimization may improve risk stratification of prostate cancer patients.
Urology 2001;57(2):286-90.
2001: D'Amico A V; Wu Y; Chen M H; Nash M; Renshaw A A; Richie J P
Perineural invasion as a predictor of biochemical outcome following radical prostatectomy for select men with clinically localized prostate cancer.
The Journal of urology 2001;165(1):126-9.
2000: Cormack R A; Tempany C M; D'Amico A V
Optimizing target coverage by dosimetric feedback during prostate brachytherapy.
International journal of radiation oncology, biology, physics 2000;48(4):1245-9.
2000: D'Amico A V; Wu Y; Chen M H; Nash M; Renshaw A A; Richie J P
Pathologic findings and prostate specific antigen outcome after radical prostatectomy for patients diagnosed on the basis of a single microscopic focus of prostate carcinoma with a gleason score </= 7.
Cancer 2000;89(8):1810-7.
2000: Cormack R A; D'Amico A V; Hata N; Silverman S; Weinstein M; Tempany C M
Feasibility of transperineal prostate biopsy under interventional magnetic resonance guidance.
Urology 2000;56(4):663-4.
2000: D'Amico A V; Whittington R; Malkowicz S B; Wu Y H; Chen M H; Hurwitz M; Kantoff P W; Tomaszewski J E; Renshaw A A; Wein A; Richie J P
Utilizing predictions of early prostate-specific antigen failure to optimize patient selection for adjuvant systemic therapy trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(18):3240-6.
2000: D'Amico A V; Schultz D; Loffredo M; Dugal R; Hurwitz M; Kaplan I; Beard C J; Renshaw A A; Kantoff P W
Biochemical outcome following external beam radiation therapy with or without androgen suppression therapy for clinically localized prostate cancer.
JAMA : the journal of the American Medical Association 2000;284(10):1280-3.
2000: D'Amico A V; Whittington R; Malkowicz B; Schnall M; Schultz D; Cote K; Tomaszewski J E; Wein A
Endorectal magnetic resonance imaging as a predictor of biochemical outcome after radical prostatectomy in men with clinically localized prostate cancer.
The Journal of urology 2000;164(3 Pt 1):759-63.
2000: Olumi A F; Richie J P; Schultz D J; D'Amico A V
Calculated volume of prostate cancer identifies patients with clinical stage T1C disease at high risk of biochemical recurrence after radical prostatectomy: a preliminary study.
Urology 2000;56(2):273-7.
2000: D'Amico A V; Tempany C M; Cormack R; Hata N; Jinzaki M; Tuncali K; Weinstein M; Richie J P
Transperineal magnetic resonance image guided prostate biopsy.
The Journal of urology 2000;164(2):385-7.
2000: Thomas M D; Cormack R; Tempany C M; Kumar S; Manola J; Schneider L; Hurwitz M D; D'Amico A V
Identifying the predictors of acute urinary retention following magnetic-resonance-guided prostate brachytherapy.
International journal of radiation oncology, biology, physics 2000;47(4):905-8.
2000: D'Amico A V; Schultz D; Schneider L; Hurwitz M; Kantoff P W; Richie J P
Comparing prostate specific antigen outcomes after different types of radiotherapy management of clinically localized prostate cancer highlights the importance of controlling for established prognostic factors.
The Journal of urology 2000;163(6):1797-801.
2000: Hurwitz M D; Cormack R; Tempany C M; Kumar S; D'Amico A V
Three-dimensional real-time magnetic resonance-guided interstitial prostate brachytherapy optimizes radiation dose distribution resulting in a favorable acute side effect profile in patients with clinically localized prostate cancer.
Techniques in urology 2000;6(2):89-94.
2000: D'Amico A; Cormack R; Kumar S; Tempany C M
Real-time magnetic resonance imaging-guided brachytherapy in the treatment of selected patients with clinically localized prostate cancer.
Journal of endourology / Endourological Society 2000;14(4):367-70.
2000: D'Amico A V; Whittington R; Malkowicz S B; Schultz D; Tomaszewski J E; Wein A
Prostate specific antigen outcome based on the extent of extracapsular extension and margin status in patients with seminal vesicle negative prostate carcinoma of Gleason score < or = 7.
Cancer 2000;88(9):2110-5.
2000: D'Amico A V; Weinstein M; Li X; Richie J P; Fujimoto J
Optical coherence tomography as a method for identifying benign and malignant microscopic structures in the prostate gland.
Urology 2000;55(5):783-7.
2000: D'Amico A V; Whittington R; Malkowicz S B; Wu Y H; Chen M; Art M; Tomaszewski J E; Wein A
Combination of the preoperative PSA level, biopsy gleason score, percentage of positive biopsies, and MRI T-stage to predict early PSA failure in men with clinically localized prostate cancer.
Urology 2000;55(4):572-7.
2000: D'Amico A V; Whittington R; Malkowicz S B; Schultz D; Fondurulia J; Chen M H; Tomaszewski J E; Renshaw A A; Wein A; Richie J P
Clinical utility of the percentage of positive prostate biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(6):1164-72.
2000: Cormack R A; Kooy H; Tempany C M; D'Amico A V
A clinical method for real-time dosimetric guidance of transperineal 125I prostate implants using interventional magnetic resonance imaging.
International journal of radiation oncology, biology, physics 2000;46(1):207-14.
2000: Kooy H M; Cormack R A; Mathiowitz G; Tempany C; D'Amico A V
A software system for interventional magnetic resonance image-guided prostate brachytherapy.
Computer aided surgery : official journal of the International Society for Computer Aided Surgery 2000;5(6):401-13.
2000: D'Amico A V; Whittington R; Malkowicz S B; Schultz D; Silver B; Henry L; Hurwitz M; Kaplan I; Beard C J; Tomaszewski J E; Renshaw A A; Wein A; Richie J P
Clinical utility of percent-positive prostate biopsies in predicting biochemical outcome after radical prostatectomy or external-beam radiation therapy for patients with clinically localized prostate cancer.
Molecular urology 2000;4(3):171-5;discussion 177.
1999: D'Amico A V; Whittington R; Malkowicz S B; Schultz D; Renshaw A A; Tomaszewski J E; Richie J P; Wein A
Optimizing patient selection for dose escalation techniques using the prostate-specific antigen level, biopsy gleason score, and clinical T-stage.
International journal of radiation oncology, biology, physics 1999;45(5):1227-33.
1999: D'Amico A V; Renshaw A A; Schultz D; Rocha S; Richie J P
The impact of the biopsy Gleason score on PSA outcome for prostate cancer patients with PSA < or = 10 ng/ml and T1c,2a: implications for patient selection for prostate-only therapy.
International journal of radiation oncology, biology, physics 1999;45(4):847-51.
1999: D'Amico A V; Renshaw A A; Arsenault L; Schultz D; Richie J P
Clinical predictors of upgrading to Gleason grade 4 or 5 disease at radical prostatectomy: potential implications for patient selection for radiation and androgen suppression therapy.
International journal of radiation oncology, biology, physics 1999;45(4):841-6.
1999: D'Amico A V; Vogelzang N J
Prostate brachytherapy: increasing demand for the procedure despite the lack of standardized quality assurance and long term outcome data.
Cancer 1999;86(9):1632-4.
1999: D'Amico A V; Debruyne F; Huland H; Richie J P
Innovative treatment for clinically localized adenocarcinoma of the prostate: the future role of molecular imaging.
The Prostate 1999;41(3):208-12.
1999: Prosnitz R G; Schneider L; Manola J; Rocha S; Loffredo M; Lopes L; D'Amico A V
Tamsulosin palliates radiation-induced urethritis in patients with prostate cancer: results of a pilot study.
International journal of radiation oncology, biology, physics 1999;45(3):563-6.
1999: Vargas S O; Jiroutek M; D'Amico A V; Renshaw A A
Distribution of carcinoma in radical prostatectomy specimens in the era of serum prostate-specific antigen testing. Implications for delivery of localized therapy.
American journal of clinical pathology 1999;112(3):373-6.
1999: D'Amico A V
Analysis of the clinical utility of the use of salvage brachytherapy in patients who have a rising PSA after definitive external beam radiation therapy.
Urology 1999;54(2):201-3.
1999: Renshaw A A; Richie J P; Loughlin K R; Jiroutek M; Chung A; D'Amico A V
Maximum diameter of prostatic carcinoma is a simple, inexpensive, and independent predictor of prostate-specific antigen failure in radical prostatectomy specimens. Validation in a cohort of 434 patients.
American journal of clinical pathology 1999;111(5):641-4.
1999: D'Amico A V; Davis A; Vargas S O; Renshaw A A; Jiroutek M; Richie J P
Defining the implant treatment volume for patients with low risk prostate cancer: does the anterior base need to be treated?
International journal of radiation oncology, biology, physics 1999;43(3):587-90.
1999: Vargas S O; Jiroutek M; Welch W R; Nucci M R; D'Amico A V; Renshaw A A
Perineural invasion in prostate needle biopsy specimens. Correlation with extraprostatic extension at resection.
American journal of clinical pathology 1999;111(2):223-8.
1999: D'Amico A V; Whittington R; Malkowicz S B; Fondurulia J; Chen M H; Kaplan I; Beard C J; Tomaszewski J E; Renshaw A A; Wein A; Coleman C N
Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(1):168-72.
1998: D'Amico A V; Whittington R; Malkowicz S B; Fondurulia J; Chen M H; Tomaszewski J E; Wein A
The combination of preoperative prostate specific antigen and postoperative pathological findings to predict prostate specific antigen outcome in clinically localized prostate cancer.
The Journal of urology 1998;160(6 Pt 1):2096-101.
1998: D'Amico A V; Desjardin A; Chen M H; Paik S; Schultz D; Renshaw A A; Loughlin K R; Richie J P
Analyzing outcome-based staging for clinically localized adenocarcinoma of the prostate.
Cancer 1998;83(10):2172-80.
1998: D'Amico A V; Cormack R; Tempany C M; Kumar S; Topulos G; Kooy H M; Coleman C N
Real-time magnetic resonance image-guided interstitial brachytherapy in the treatment of select patients with clinically localized prostate cancer.
International journal of radiation oncology, biology, physics 1998;42(3):507-15.
1998: D'Amico A V; Whittington R; Malkowicz S B; Schultz D; Tomaszewski J E; Wein A
A prostate gland volume of more than 75 cm3 predicts for a favorable outcome after radical prostatectomy for localized prostate cancer.
Urology 1998;52(4):631-6.
1998: D'Amico A V; Whittington R; Malkowicz S B; Schultz D; Blank K; Broderick G A; Tomaszewski J E; Renshaw A A; Kaplan I; Beard C J; Wein A
Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.
JAMA : the journal of the American Medical Association 1998;280(11):969-74.
1998: D'Amico A V; Whittington R; Malkowicz S B; Schultz D; Kaplan I; Beard C J; Tomaszewski J E; Renshaw A A; Loughlin K R; Richie J P; Wein A
Calculated prostate cancer volume greater than 4.0 cm3 identifies patients with localized prostate cancer who have a poor prognosis following radical prostatectomy or external-beam radiation therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(9):3094-100.
1998: D'Amico A V; Desjardin A; Chung A; Chen M H
Assessment of outcome prediction models for localized prostate cancer in patients managed with external beam radiation therapy.
Seminars in urologic oncology 1998;16(3):153-9.
1998: Renshaw A A; Richie J P; Loughlin K R; Jiroutek M; Chung A; D'Amico A V
The greatest dimension of prostate carcinoma is a simple, inexpensive predictor of prostate specific antigen failure in radical prostatectomy specimens.
Cancer 1998;83(4):748-52.
1998: Beard C J; Lamb C; Buswell L; Schneider L; Propert K J; Gladstone D; D'Amico A; Kaplan I
Radiation-associated morbidity in patients undergoing small-field external beam irradiation for prostate cancer.
International journal of radiation oncology, biology, physics 1998;41(2):257-62.
1998: D'Amico A V; Desjardin A; Chung A; Chen M H; Schultz D; Whittington R; Malkowicz S B; Wein A; Tomaszewski J E; Renshaw A A; Loughlin K; Richie J P
Assessment of outcome prediction models for patients with localized prostate carcinoma managed with radical prostatectomy or external beam radiation therapy.
Cancer 1998;82(10):1887-96.
1998: D'Amico A V; Schnall M; Whittington R; Malkowicz S B; Schultz D; Tomaszewski J E; Wein A
Endorectal coil magnetic resonance imaging identifies locally advanced prostate cancer in select patients with clinically localized disease.
Urology 1998;51(3):449-54.
1998: D'Amico A V; Chang E; Garnick M; Kantoff P; Jiroutek M; Tempany C M
Assessment of prostate cancer volume using endorectal coil magnetic resonance imaging: a new predictor of tumor response to neoadjuvant androgen suppression therapy.
Urology 1998;51(2):287-92.
1998: D'Amico A V; Whittington R; Kaplan I; Beard C; Schultz D; Malkowicz S B; Wein A; Tomaszewski J E; Coleman C N
Calculated prostate carcinoma volume: The optimal predictor of 3-year prostate specific antigen (PSA) failure free survival after surgery or radiation therapy of patients with pretreatment PSA levels of 4-20 nanograms per milliliter.
Cancer 1998;82(2):334-41.
1997: D'Amico A V; Whittington R; Schultz D; Malkowicz S B; Tomaszewski J E; Wein A
Outcome based staging for clinically localized adenocarcinoma of the prostate.
The Journal of urology 1997;158(4):1422-6.
1997: D'Amico A V; Whittington R; Kaplan I; Beard C; Schultz D; Malkowicz S B; Tomaszewski J E; Wein A; Coleman C N
Equivalent 5-year bNED in select prostate cancer patients managed with surgery or radiation therapy despite exclusion of the seminal vesicles from the CTV.
International journal of radiation oncology, biology, physics 1997;39(2):335-40.
1997: Werner-Wasik M; Whittington R; Malkowicz S B; Corn B W; Arger P; Reisinger S; Langlotz C; Alexander A; D'Amico A V; Hyslop T; Gomella L; Brownstein K; Wein A J
Prostate imaging may not be necessary in nonpalpable carcinoma of the prostate.
Urology 1997;50(3):385-9.
1997: Renshaw A A; Chang H; D'Amico A V
Estimation of tumor volume in radical prostatectomy specimens in routine clinical practice.
American journal of clinical pathology 1997;107(6):704-8.
1997: D'Amico A V; Whittington R; Malkowicz S B; Schultz D; Tomaszewski J E; Wein A
Prostate-specific antigen failure despite pathologically organ-confined and margin-negative prostate cancer: the basis for an adjuvant therapy trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(4):1465-9.
1997: D'Amico A V
Re: Endo-rectal coil magnetic resonance imaging in clinically localized prostate cancer: is it accurate?
The Journal of urology 1997;157(4):1371; author reply 1372.
1997: D'Amico A V; Whittington R; Kaplan I; Beard C; Jiroutek M; Malkowicz S B; Wein A; Coleman C N
Equivalent biochemical failure-free survival after external beam radiation therapy or radical prostatectomy in patients with a pretreatment prostate specific antigen of > 4-20 ng/ml.
International journal of radiation oncology, biology, physics 1997;37(5):1053-8.
1997: D'Amico A V; Whittington R; Malkowicz S B; Schultz D; Schnall M; Tomaszewski J E; Wein A
Combined modality staging of prostate carcinoma and its utility in predicting pathologic stage and postoperative prostate specific antigen failure.
Urology 1997;49(3A Suppl):23-30.
1997: D'Amico A V; Chang H; Holupka E; Renshaw A; Desjarden A; Chen M; Loughlin K R; Richie J P
Calculated prostate cancer volume: the optimal predictor of actual cancer volume and pathologic stage.
Urology 1997;49(3):385-91.
1997: D'Amico A V; Matelski H; O'Leary M; Sussman B
Prostate-specific antigen-producing cells in the bone marrow of a patient with early-stage prostate cancer.
Urology 1997;49(2):279-82.
1996: D'Amico A V; Whittington R; Malkowicz S B; Schultz D; Schnall M; Tomaszewski J E; Wein A
Role of percent positive biopsies and endorectal coil MRI in predicting prognosis in intermediate-risk prostate cancer patients.
The cancer journal from Scientific American 1996;2(6):343-50.
1996: D'Amico A V
The role of MR imaging in the selection of therapy for prostate cancer.
Magnetic resonance imaging clinics of North America 1996;4(3):471-9.
1996: D'Amico A V; Whittington R; Malkowicz S B; Schultz D; Schnall M; Tomaszewski J E; Wein A
Critical analysis of the ability of the endorectal coil magnetic resonance imaging scan to predict pathologic stage, margin status, and postoperative prostate-specific antigen failure in patients with clinically organ-confined prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(6):1770-7.
1996: D'Amico A V; Goldwein J; Womer R
Alveolar rhabdomyosarcoma of the lip in an infant.
Medical and pediatric oncology 1996;26(6):409-13.
1996: D'Amico A V; Propert K J
Prostate cancer volume adds significantly to prostate-specific antigen in the prediction of early biochemical failure after external beam radiation therapy.
International journal of radiation oncology, biology, physics 1996;35(2):273-9.
1996: D'Amico A V; Whittington R; Malkowicz S B; Loughlin K; Schultz D; Schnall M; Tempany C M; Tomaszewski J E; Renshaw A; Wein A
An analysis of the time course of postoperative prostate-specific antigen failure in patients with positive surgical margins: implications on the use of adjuvant therapy.
Urology 1996;47(4):538-47.
1996: D'Amico A V; Kaplan I
Select transition zone prostate cancers may be radiocurable despite markedly elevated prostate-specific antigen levels.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1996;38(1):73-6.
1996: D'Amico A V; Coleman C N
Role of interstitial radiotherapy in the management of clinically organ-confined prostate cancer: the jury is still out.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(1):304-15.
1995: D'Amico A V; Whittington R; Malkowicz S B; Schultz D; Schnall M; Tomaszewski J E; Wein A
A multivariate analysis of clinical and pathological factors that predict for prostate specific antigen failure after radical prostatectomy for prostate cancer.
The Journal of urology 1995;154(1):131-8.
1995: D'Amico A V; Whittington R; Malkowicz S B; Schultz D
A method for determining a prostate-specific antigen cure after radiation therapy for clinically localized prostate cancer.
International journal of radiation oncology, biology, physics 1995;32(2):473-7.
1995: D'Amico A V; Whittington R; Schnall M; Malkowicz S B; Tomaszewski J E; Schultz D; Wein A
The impact of the inclusion of endorectal coil magnetic resonance imaging in a multivariate analysis to predict clinically unsuspected extraprostatic cancer.
Cancer 1995;75(9):2368-72.
1994: Kao G D; Malkowicz S B; Whittington R; D'Amico A V; Wein A J
Locally advanced renal cell carcinoma: low complication rate and efficacy of postnephrectomy radiation therapy planned with CT.
Radiology 1994;193(3):725-30.
1994: D'Amico A V; McKenna W G
Apoptosis and a re-investigation of the biologic basis for cancer therapy.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1994;33(1):3-10.
1994: D'Amico A V; Whittington R; Malkowicz S B; Schnall M; Tomaszewski J; Schultz D; Kao G; VanArsdalen K; Wein A
A multivariable analysis of clinical factors predicting for pathological features associated with local failure after radical prostatectomy for prostate cancer.
International journal of radiation oncology, biology, physics 1994;30(2):293-302.
1993: D'Amico A V; Hanks G E
Linear regressive analysis using prostate-specific antigen doubling time for predicting tumor biology and clinical outcome in prostate cancer.
Cancer 1993;72(9):2638-43.
1993: D'Amico A; Altschuler M; Whittington R; Kao G; Malkowicz S B; Wein A
The use of clinical parameters in an interactive statistical package to predict pathological features associated with local failure after radical prostatectomy for prostate cancer.
Clinical performance and quality health care 1993;1(4):219-22.
1993: Hanks G E; D'Amico A; Epstein B E; Schultheiss T E
Prostatic-specific antigen doubling times in patients with prostate cancer: a potentially useful reflection of tumor doubling time.
International journal of radiation oncology, biology, physics 1993;27(1):125-7.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Anthony D'Amico

Research Profile (preview)

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Anatomy

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Anthony D'Amico (preview)

All Publications